Content - SAKK 08/15 and SAKK 17/16 are activated

SAKK 08/15 and SAKK 17/16 are activated

SAKK has activated two new trials.

SAKK 08/15 PROMET – Can the diabetes medicine metformin also be used to treat prostate cancer?

In this trial, we will investigate whether and to what extent metformin is effective, well tolerated and safe in combination with radiotherapy for patients with prostate cancer who have a recurrence after removal of the prostate gland.

 

SAKK 17/16 – Efficacy and safety of lurbinectedin in case of pleural mesothelioma

In this trial, we investigate the efficacy and safety of chemotherapy with lurbinectedin to treat progressive pleural mesothelioma.

 

 

All news